Patent details

EP1539818 Title: COMPOSITIONS AND USES THEREOF FOR IDENTIFYING AND TARGETING PROVASOPRESSIN-EXPRESSING CANCER CELLS

Basic Information

Publication number:
EP1539818
PCT Application Number:
PCT/US/2003/022264
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037647500
PCT Publication Number:
WO/2004/006860
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS AND USES THEREOF FOR IDENTIFYING AND TARGETING PROVASOPRESSIN-EXPRESSING CANCER CELLS
French Title of Invention:
COMPOSITIONS PERMETTANT D'IDENTIFIER ET DE CIBLER DES CELLULES CANCEREUSES EXPRIMANT UNE PROVASOPRESSINE ET UTILISATIONS
German Title of Invention:
ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN ZUR IDENTIFIZIERUNG UND ZUM TARGETTING VON PROVASOPRESSINEXPRIMIERENDEN KREBSZELLEN
SPC Number:

Dates

Filing date:
16/07/2003
Grant date:
15/12/2010
EP Publication Date:
15/12/2010
PCT Publication Date:
22/01/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/06/2005
EP B1 Publication Date:
15/12/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/07/2011
Expiration date:
16/07/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/07/2003
 
 

Name:
WOOMERA THERAPEUTICS INC.
Address:
34 Low Road, Hanover, NH 03755, United States (US)

Inventor

1

Name:
NORTH William, G.
Address:
United States (US)

2

Name:
OLIGINO Lyn
Address:
United States (US)

3

Name:
KEEGAN Brendan, P.
Address:
United States (US)

Priority

Priority Number:
396121 P
Priority Date:
16/07/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/26;
Filing date Document type Number of pages